These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 10974034

  • 1. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells.
    Abrams JR, Kelley SL, Hayes E, Kikuchi T, Brown MJ, Kang S, Lebwohl MG, Guzzo CA, Jegasothy BV, Linsley PS, Krueger JG.
    J Exp Med; 2000 Sep 04; 192(5):681-94. PubMed ID: 10974034
    [Abstract] [Full Text] [Related]

  • 2. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.
    Abrams JR, Lebwohl MG, Guzzo CA, Jegasothy BV, Goldfarb MT, Goffe BS, Menter A, Lowe NJ, Krueger G, Brown MJ, Weiner RS, Birkhofer MJ, Warner GL, Berry KK, Linsley PS, Krueger JG, Ochs HD, Kelley SL, Kang S.
    J Clin Invest; 1999 May 04; 103(9):1243-52. PubMed ID: 10225967
    [Abstract] [Full Text] [Related]

  • 3. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
    Li W, Lu L, Wang Z, Wang L, Fung JJ, Thomson AW, Qian S.
    Transplantation; 2001 Oct 27; 72(8):1423-32. PubMed ID: 11685115
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
    Ferenczi K, Burack L, Pope M, Krueger JG, Austin LM.
    J Autoimmun; 2000 Feb 27; 14(1):63-78. PubMed ID: 10648117
    [Abstract] [Full Text] [Related]

  • 6. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
    Lin H, Wei RQ, Goodman RE, Bolling SF.
    Surgery; 1997 Aug 27; 122(2):129-37. PubMed ID: 9288115
    [Abstract] [Full Text] [Related]

  • 7. Characterization of human inducible costimulator ligand expression and function.
    Aicher A, Hayden-Ledbetter M, Brady WA, Pezzutto A, Richter G, Magaletti D, Buckwalter S, Ledbetter JA, Clark EA.
    J Immunol; 2000 May 01; 164(9):4689-96. PubMed ID: 10779774
    [Abstract] [Full Text] [Related]

  • 8. [Regulation of T-cell activation by CD28 and CTLA-4].
    Nagel T, Kalden JR, Manger B.
    Med Klin (Munich); 1998 Oct 15; 93(10):592-7. PubMed ID: 9849050
    [Abstract] [Full Text] [Related]

  • 9. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
    Peach RJ, Bajorath J, Brady W, Leytze G, Greene J, Naemura J, Linsley PS.
    J Exp Med; 1994 Dec 01; 180(6):2049-58. PubMed ID: 7964482
    [Abstract] [Full Text] [Related]

  • 10. Blockade of CD28/B7-2 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts: suppression of helper T cell type1-dominated immune response.
    Tikkanen JM, Lemström KB, Koskinen PK.
    Am J Respir Crit Care Med; 2002 Mar 01; 165(5):724-9. PubMed ID: 11874822
    [Abstract] [Full Text] [Related]

  • 11. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
    Via CS, Rus V, Nguyen P, Linsley P, Gause WC.
    J Immunol; 1996 Nov 01; 157(9):4258-67. PubMed ID: 8892665
    [Abstract] [Full Text] [Related]

  • 12. Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts.
    Glysing-Jensen T, Räisänen-Sokolowski A, Sayegh MH, Russell ME.
    Transplantation; 1997 Dec 27; 64(12):1641-5. PubMed ID: 9422395
    [Abstract] [Full Text] [Related]

  • 13. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, Linsley PS, Bromberg JS, Baliga P.
    Transplantation; 1996 Oct 15; 62(7):1011-8. PubMed ID: 8878397
    [Abstract] [Full Text] [Related]

  • 14. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.
    Akalin E, Chandraker A, Russell ME, Turka LA, Hancock WW, Sayegh MH.
    Transplantation; 1996 Dec 27; 62(12):1942-5. PubMed ID: 8990393
    [Abstract] [Full Text] [Related]

  • 15. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
    Van Gool SW, Zhang Y, Kasran A, de Boer M, Ceuppens JL.
    Scand J Immunol; 1996 Jul 27; 44(1):21-9. PubMed ID: 8693288
    [Abstract] [Full Text] [Related]

  • 16. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
    Kim KS, Denton MD, Chandraker A, Knoflach A, Milord R, Waaga AM, Turka LA, Russell ME, Peach R, Sayegh MH.
    Am J Pathol; 2001 Mar 27; 158(3):977-86. PubMed ID: 11238045
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses.
    Blazevic V, Trubey CM, Shearer GM.
    J Clin Immunol; 2001 Jul 27; 21(4):293-302. PubMed ID: 11506200
    [Abstract] [Full Text] [Related]

  • 18. CTLA4-Ig: a novel immunosuppressive agent.
    Najafian N, Sayegh MH.
    Expert Opin Investig Drugs; 2000 Sep 27; 9(9):2147-57. PubMed ID: 11060799
    [Abstract] [Full Text] [Related]

  • 19. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
    Carreno BM, Bennett F, Chau TA, Ling V, Luxenberg D, Jussif J, Baroja ML, Madrenas J.
    J Immunol; 2000 Aug 01; 165(3):1352-6. PubMed ID: 10903737
    [Abstract] [Full Text] [Related]

  • 20. The CD28-B7 costimulatory pathway and its role in autoimmune disease.
    Daikh D, Wofsy D, Imboden JB.
    J Leukoc Biol; 1997 Aug 01; 62(2):156-62. PubMed ID: 9261329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.